Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, +380

The Lancet

Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease +5

Cytokines and Nash: A Pilot Study of the Effects of Lifestyle Modification and Vitamin E

Marcelo Kugelmas, Daniell B. Hill, Beverly Vivian, +2

Hepatology

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue, +632

Journal of Hepatology

FibrosisHepatologyLiver PhysiologyClinical TrialsPathology +7

NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Stephen A. Harrison, Mary E. Rinella, Manal F. Abdelmalek, +10

The Lancet

HepatologyMedicineLiver PhysiologyNon-alcoholic SteatohepatitisLiver Disease +3

Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy†

Gregory T. Everson, James F. Trotter, Lisa Forman, +4

Hepatology

Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial

Mark Sulkowski, Christophe Hézode, Jan Gerstoft, +20

The Lancet

Open-label Phase 2Hepatitis CViral HepatitisAntiviral Drug DevelopmentAntiviral Therapy +6

Right hepatic lobe donation for living donor liver transplantation: Impact on donor quality of life

James F. Trotter, Michael Talamantes, Mary McClure, +6

Liver Transplantation

Quality Of LifeOrgan DonationSolid Organ TransplantationAugust 2000Donor Surgery +16

NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Harrison SA, Rinella Me, MF Abdelmalek, +9

Yearbook of pediatric endocrinology

PathologyFatty Liver DiseaseCholangiopathiesInflammationMetabolic Syndrome +19

Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST‐2)

Eric Lawitz, Gary Matusow, Edwin DeJesus, +17

Hepatology

Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation

Marcelo Kugelmas, Purnima Spiegelman, Michael J. Osgood, +7

Liver Transplantation

Liver Transplant RecipientsSolid Organ TransplantationImmunologyPathologyPrimary Biliary Cirrhosis +19